Beijing, China

Guangxing Yin


Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2024

where 'Filed Patents' based on already Granted Patents

1 patent (USPTO):

Title: Innovations in Tumor Diagnosis and Treatment by Inventor Guangxing Yin

Introduction

Guangxing Yin, a noteworthy inventor based in Beijing, China, has made significant contributions to the field of cancer diagnostics and therapeutics. He is recognized for his pioneering work in developing innovative compounds that can enhance the effectiveness of tumor treatments.

Latest Patents

Guangxing Yin holds one notable patent titled "Mannose derivative and application thereof." This patent encompasses an isonitrile-containing mannose derivative defined by a specific formula. The invention involves a radioactive preparation that includes a radiolabeled compound created by radiolabeling the mannose derivative with a radionuclide. This development has promising applications in the diagnosis and treatment of tumors, potentially paving new avenues for patient care.

Career Highlights

Currently, Guangxing Yin is affiliated with Beijing Normal University, where his research focuses on the intersection of chemistry and medical applications. His academic prowess, coupled with innovative thinking, allows him to explore novel approaches to cancer detection and treatment.

Collaborations

Throughout his career, Guangxing Yin has worked closely with esteemed colleagues, including Junbo Zhang and Qing Ruan. These collaborations underscore the importance of teamwork in scientific endeavors and enhance the depth of research conducted within the institution.

Conclusion

In summary, Guangxing Yin is an influential figure in the realm of cancer research, with his patented innovations holding the potential to significantly impact tumor diagnosis and treatment. His work exemplifies the spirit of innovation rooted in scientific inquiry and collaboration, promising advancements that could benefit many in the medical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…